PFIZER INC — Major Shareholding Notification 2001

Jan 3, 2001

SC 13G 1 aastrom_13g.htm PFIZER INC. SC 13G - FEBRUARY 25, 2000 - AASTROM Aastrom Biosciences, Inc. 13G

| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
| --- |
| SCHEDULE 13G UNDER THE SECURITIES
AND EXCHANGE COMMISSION (AMENDMENT NO.
1)* |
| Aastrom Biosciences, Inc. (Name of Issuer) |
| Common Stock, No Par Value (Title of Class of Securities) 00253U107 (CUSIP Number) |
| February 25, 2001 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the
rule pursuant to which this Schedule is filed: [ ] Rule 13d-1 (b) [x ] Rule 13d-1 (c) [ ] Rule 13d-1(d) * The remainder of this cover page shall
be filled out for a reporting person's initial filing on this form with
respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in
a prior cover page. The information required in the remainder
of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 ("Act")
or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Notes). |

CUSIP NO. 00253U107 ____________ 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pfizer Inc. 13-5315170 ___________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) &nbsp (a)_ (b) _________ 3. SEC USE ONLY ___________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware _________ 5. SOLE VOTING POWER 0 NUMBER OF _________ SHARES 6. SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 0 PERSON _______ WITH 8. SHARED DISPOSITIVE POWER _________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 _________ 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 0 ___________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0% __________ 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO ________________ ITEM 1. (a) Name of Issuer: Aastrom Biosciences, Inc. (b) Address of Issuer's Principal Executive Offices: 24 Frank Lloyd Wright Drive P. O. Box 376 Ann Arbor, MI 48106 ITEM 2. (a) Name of Person Filing: Pfizer Inc. (b) Address of Principal Business Office or, if none , Residence 235 East 42nd Street New York, NY 10017 (c) Citizenship: Delaware (d) Title of Class of Securities: Common Stock, No Par Value (e) CUSIP Number: 00253U107 ITEM 3. I F THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1 (b) OR RULE 13d-2 b) OR (c), CHECK WHETHER THE PERSON FILING IS A: Not applicable ITEM 4. OWNERSHIP (a) Amount beneficially owned: 0 (b) Percent of class: 0 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 0 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [x]. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable ITEM 10. CERTIFICATIONS Not applicable

SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

| PFIZER INC. |
| --- |
| Date: January 3, 2000 By: /s/ MARGARET
M. FORAN Name: Margaret M. Foran Title: Vice President
- Corporate Governance |